両国の研究と伝統が支える日韓がん・老化シンポジウム
スポンサーリンク
概要
- 論文の詳細を見る
In February 2011, we celebrated the 10th Japan-Korea Symposium on Cancer and Aging Research at the Tomizo Yoshida Memorial Auditorium of the Cancer Institute in Tokyo with a fruitful program. On this occasion, this paper reported on the historical development of the Symposia supported by scientists of both nations. In 1996, our three research groups: Prof. Sang Chul Park of the National Seoul University, College of Medicine, Department of Biochemistry and Molecular Biology; Prof. In Kyoung Lim of Ajou University, School of Medicine, Department of Biochemistry and Molecular Biology; and our Saitama Cancer Center Research Institute held the first Joint Symposium at the Kang-nung National University. From the beginning we identified the two main aims of our Symposia: (1) to encourage young scientists to present their work without hesitation in English and discuss their results in a relaxed environment, and (2) to get to know one another during the meeting and excursions associated with the history of our nations. In the light of our successful academic collaborations, Prof. Park was asked to establish an editorial office in Korea and to work for the Journal of Cancer Research and Clinical Oncology in collaboration with Prof. Lim in Seoul. This journal started in 1903 is the oldest journal of cancer research, and is now well supported by scientists of Korea and Japan. This review article deals with numerous topics including highlights of our joint Symposia, the academic activity of the Journal of Cancer Research and Clinical Oncology, the relationship between our two aims and the philosophy of Mr. Houshu Amenomori, the latter of which was introduced by President Noteu in 1999 in Tokyo, and the book of Dr. Gozo Sato reporting on the development of medical education before 1945 in Korea. In addition, the biochemical activity of Dr.Kaichiro Kuroda, who graduated from the Faculty of Medicine at Keijo Imperial University, in 1930 and worked at the Department of Medical Chemistry in collaboration with Prof. Hiroshi Nakamura,was discussed. The academic activity in Korea by Dr. Sato and Dr. Kuroda, who was later the second President of Tokushima Bunri University, demonstrated that the relationship between Korean and Japanese scientists began 100 years ago. We can proud that our scientific collaborations are still continuing today.
著者
関連論文
- 白血病関連遺伝子MTG8の造腫瘍性と核内局在化との関連
- THE STRUCTURES OF ADDITIONAL TELEOCIDIN CLASS TUMOR PROMOTERS
- 新しい環境性発癌プロモ-タ-とその生物学的作用 (発癌とプロモ-ション) -- (発癌における各種プロモ-タ-とその特性)
- 59 トウダイグサ科植物Aleurites fordiiおよびEuphorbia cotinifoliaの生物活性diterpene esters
- 癌悪液質モデルハウスにおけるモルヒネのサイトカイン発現抑制
- プロテインホスファターゼ阻害剤により見出されたTNF-αを介する新しい発がんプロモーション機構
- 5.海洋天然物による発癌抑制 : 第45回大会研究発表要旨 : ビタミン・バイオファクターと発癌制御
- 緑茶カテキンによるヒトがんの化学予防 : 1日10杯の緑茶飲用で多くの臓器のがん発症を予防
- 82 発がんプロモーターTeleocidin類の化学構造研究
- 83 Teleocidin誘導体の合成,立体配座解析および生物活性
- 医療トレンド-6 緑茶カテキンと薬の併用による相乗的がん予防効果
- 癌の予防法--生活習慣病態対策 (特集 高齢者の癌をどうするか(1))
- 癌を知るキーコンセプト(8)癌の化学予防
- 茶ポリフェノールによる発がん抑制機構
- 重症複合型免疫不全(SCID)マウスの発がん二段階実験に対する抵抗性の生化学的研究
- 腫瘍壊死因子(TNF-α)は内因性発癌プロモーターか? サイトカインネットワークの関与を考えた新しい発癌プロモーション機構
- プロテインホスファタ-ゼの阻害剤と活性化剤 (プロテインホスファタ-ゼ--最近の進歩)
- EGCGによるヒト癌の化学予防 (食品関連成分と発癌抑制)
- プロテインホスファタ-ゼ阻害剤 (細胞機能研究のための低分子プロ-ブ) -- (酵素阻害物質)
- 海産発癌プロモーターと抗発癌プロモーター
- 発がんプロモ-ションの抑制 (がんは防げるか)
- 海洋天然物に由来する発癌および抗発癌プロモ-タ---続々と新しいタイプの化合物が登場.海洋生物にとっての意味は何か(今日の話題)
- 1P019 Aeromonas sobria由来セリンプロテアーゼのX線結晶構造解析(蛋白質 A) 構造))
- ISOLATION AND STRUCTURE ELUCIDATION OF TELEOCIDIN B-1,B-2,B-3,AND B-4
- 緑茶カテキン研究の新展開 : がん予防におけるカテキンと核酸との相互作用
- EGCGによるヒト癌の化学予防
- 両国の研究と伝統が支える日韓がん・老化シンポジウム
- Professor Kaichiro Kuroda and Scientific Activity at The Department of Medical Chemistry of Keijo Imperial University in Korea (1930-1941)